US Stock MarketDetailed Quotes
SNTI Senti Biosciences
- 1.8300
- +0.2500+15.82%
Close Aug 8 16:00 ET
- 1.8300
- 0.00000.00%
Post 17:22 ET
8.37MMarket Cap-127P/E (TTM)
2.2000High1.5800Low200.08KVolume1.6000Open1.5800Pre Close396.18KTurnover6.86%Turnover RatioLossP/E (Static)4.58MShares8.479052wk High0.15P/B5.34MFloat Cap1.520152wk Low--Dividend TTM2.92MShs Float105.4000Historical High--Div YieldTTM39.24%Amplitude1.5200Historical Low1.9800Avg Price1Lot Size
Senti Biosciences Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | -39.81%1.98M | 0 | -83.18%255K | -38.00%687K | 21.31%1.04M | 43.43%3.29M | -135.17%-191K | 63.71%1.52M | 42.42%1.11M |
| Operating revenue | --0 | -39.81%1.98M | --0 | -83.18%255K | -38.00%687K | 21.31%1.04M | 43.43%3.29M | -135.17%-191K | 63.71%1.52M | 42.42%1.11M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 1.88%16.3M | 5.16%68.74M | 10.99%18.43M | 13.38%18.44M | -11.18%20.32M | 26.86%16M | 52.96%65.37M | 45.28%16.6M | 31.70%16.26M | 134.08%22.88M |
| Selling and administrative expenses | -24.54%6.8M | -7.35%34.87M | -24.14%7M | -5.64%9.43M | -30.70%9.62M | 71.31%9.01M | 77.10%37.63M | 75.06%9.22M | 40.46%10M | 204.83%13.88M |
| -General and administrative expense | -24.54%6.8M | -7.35%34.87M | -24.14%7M | -5.64%9.43M | -30.70%9.62M | 71.31%9.01M | 77.10%37.63M | 75.06%9.22M | 40.46%10M | 204.83%13.88M |
| Research and development costs | 24.37%8.78M | 14.23%32.15M | 29.63%9.12M | 39.47%9.09M | 18.44%10.95M | -7.16%7.06M | 28.18%28.15M | 9.80%7.04M | 20.50%6.52M | 76.64%9.25M |
| Depreciation amortization depletion | 297.80%724K | 289.86%2.31M | ---- | ---- | ---- | --182K | --592K | ---- | ---- | ---- |
| -Depreciation and amortization | 297.80%724K | 289.86%2.31M | ---- | ---- | ---- | --182K | --592K | ---- | ---- | ---- |
| Other operating expenses | ---- | 41.70%-583K | --0 | 66.80%-83K | 0.00%-250K | 0.00%-250K | -112.77%-1M | 0.00%-250K | -41.24%-250K | -1,566.67%-250K |
| Operating profit | -8.93%-16.3M | -7.54%-66.77M | -9.72%-18.43M | -23.30%-18.19M | 9.81%-19.64M | -27.27%-14.96M | -53.50%-62.08M | -54.29%-16.79M | -29.11%-14.75M | -142.01%-21.77M |
| Net non-operating interest income expense | -68.80%331K | 68.37%2.86M | -62.23%426K | 7.56%583K | 2,840.74%794K | 26,425.00%1.06M | 15,363.64%1.7M | 28,100.00%1.13M | 10,740.00%542K | 1,250.00%27K |
| Non-operating interest income | -68.80%331K | 68.37%2.86M | -62.23%426K | 7.56%583K | 2,840.74%794K | 26,425.00%1.06M | 15,363.64%1.7M | 28,100.00%1.13M | 10,740.00%542K | 1,250.00%27K |
| Other net income (expense) | 7,466.67%3.86M | -281.98%-19.51M | -201.33%-687K | -19,501.03%-19.01M | -98.59%144K | 194.44%51K | 172.01%10.72M | 3,047.83%678K | -908.33%-97K | 438.27%10.19M |
| Gain on sale of security | --2.4M | --3.96M | ---1.83M | --5.79M | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | --0 | -339.58%-25.76M | -139.74%-271K | -25,850.51%-25.69M | -98.54%148K | --59K | 48,963.64%10.75M | 5,346.15%682K | -1,000.00%-99K | --10.17M |
| -Less：Restructuring and merger&acquisition | --0 | 97.81%-207K | --0 | --0 | 98.33%-148K | ---59K | ---9.46M | ---682K | --99K | ---8.88M |
| -Less:Impairment of capital assets | ---- | --25.96M | --271K | --25.69M | ---- | ---- | --0 | --0 | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---1.29M | --0 | ---- | ---1.29M |
| Other non- operating income (expenses) | 18,362.50%1.46M | 7,256.25%2.29M | 35,525.00%1.42M | 44,150.00%885K | -116.00%-4K | 85.19%-8K | 99.78%-32K | 60.00%-4K | -90.48%2K | 100.83%25K |
| Income before tax | 12.57%-12.11M | -67.94%-83.41M | -24.69%-18.69M | -156.00%-36.62M | -61.85%-18.7M | -17.31%-13.85M | 10.22%-49.67M | -37.45%-14.99M | -25.40%-14.3M | 3.79%-11.55M |
| Income tax | ||||||||||
| Net income | 35.31%-12.11M | -22.07%-71.06M | -2.78%-18.72M | 10.32%-14.92M | -61.85%-18.7M | -58.55%-18.72M | -5.23%-58.21M | -67.00%-18.21M | -45.89%-16.64M | 3.79%-11.55M |
| Net income continuous Operations | 12.57%-12.11M | -67.94%-83.41M | -24.69%-18.69M | -156.00%-36.62M | -61.85%-18.7M | -17.31%-13.85M | 10.22%-49.67M | -37.45%-14.99M | -25.40%-14.3M | 3.79%-11.55M |
| Net income discontinuous operations | --0 | 244.51%12.35M | 99.13%-28K | 1,028.20%21.69M | ---- | ---4.87M | ---8.55M | ---3.22M | ---2.34M | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 35.31%-12.11M | -22.07%-71.06M | -2.78%-18.72M | 10.32%-14.92M | -61.85%-18.7M | -58.55%-18.72M | -5.23%-58.21M | -67.00%-18.21M | -45.89%-16.64M | 3.79%-11.55M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 35.31%-12.11M | -22.07%-71.06M | -2.78%-18.72M | 10.32%-14.92M | -61.85%-18.7M | -58.55%-18.72M | -5.23%-58.21M | -67.00%-18.21M | -45.89%-16.64M | 3.79%-11.55M |
| Basic earnings per share | 38.10%-2.6 | 28.25%-16 | 0.00%-4.2 | 10.53%-3.4 | 51.16%-4.2 | -55.28%-4.2 | -75.99%-22.3 | -68.16%-4.2 | -45.45%-3.8 | -212.69%-8.6 |
| Diluted earnings per share | 38.10%-2.6 | 28.25%-16 | 0.00%-4.2 | 10.53%-3.4 | 51.16%-4.2 | -55.28%-4.2 | -75.99%-22.3 | -68.16%-4.2 | -45.45%-3.8 | -212.69%-8.6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg